Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
2025/07/24

DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Regeneron Pharmaceuticals Inc. (REGN) advanced 2.04% to $572.39 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.78% to 6,358.91 and the Dow Jones Industrial Average rising 1.14% to 45,010.29.

This was the stock's third consecutive day of gains.

Regeneron Pharmaceuticals Inc. closed 52.74% short of its 52-week high of $1,211.20, which the company reached on August 27th.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Amgen Inc. $(AMGN)$ rose 1.15% to $309.22, Moderna Inc. (MRNA) rose 5.93% to $34.67, and Gilead Sciences Inc. $(GILD.UK)$ rose 3.08% to $113.56.

Trading volume (890,585) remained 372,561 below its 50-day average volume of 1.3 M.

Data source: Dow Jones Market Data, FactSet. Data compiled July 23, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

July 23, 2025 16:47 ET (20:47 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10